SUN PHARMA
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥501-1,000
📍Mumbai
SUN PHARMA

About SUN PHARMA

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the Unite...

SUN PHARMA news and updates

Sun Pharmaceutical Industries Inc. launched COVID-19 antiviral drug molnupiravir on Jan 22nd 22'.

Leading pharmaceutical company Sun Pharma recently is launching Merck Sharpe Dohme (MSD) and Ridgeback’s COVID-19 antiviral drug molnupiravir, whileDrReddys also covers a large spectrum of COVID-19 products from prevention to treatment.

Jan 1, 2022 | tribuneindia.com

Sun Pharmaceutical Industries Inc. launched ILUMYA for the treatment of plaque psoriasis on Sep 1st 20'.

In September 2020, Sun Pharma announced the launch of ILUMYA® (tildrakizumab) for the treatment of plaque psoriasis, in Japan.

Jan 1, 2022 | wfmz.com

Sun Pharmaceutical acquired Alchemee for $99.3M on Mar 7th 22'.

Last week, Sun Pharmaceutical Industries said its unit has completed the $99.3 million acquisition of Alchemee from Galderma.

Jan 1, 2022 | moneycontrol.com

Sun Pharmaceutical has issues with antitrust litigation for allegedly delaying generic versions of three drugs

Sun Pharma Settles U.S. Antitrust Litigation For $485 Million Sun Pharmaceutical Industries Ltd. has agreed to pay $485 million (about Rs 3,700 crore) to settle an antitrust litigation for allegedly delaying generic versions of three drugs in the U.S.Sun Pharma and its U.S.-based subsidiary, Ranbaxy Inc., have signed a binding agreement with two plaintiff groups to settle claims regarding the antitrust litigation, the company said in an exchange filing.

Jan 1, 2022 | bloombergquint.com

Sun Pharmaceutical partners with Lundbeck

Indian drug major Sun Pharmaceutical Industries has entered into an exclusive patent licensing agreement with Danish CNS specialist Lundbeck to market and distribute its own version of vortioxetine in India.

Jan 1, 2022 | thepharmaletter.com

Sun Pharmaceutical launched Bromsite on Sep 29th 21'.

In 2016, Sun Pharma has introduced Bromsite, its first branded ophthalmic drug, in the U.S.

Jan 1, 2021 | medgadget.com

Sun Pharmaceutical launches campaign called #NekiEbadat

The Sun Pharm brand launched a campaign called #NekiEbadat that inspires people to take a step forward and help others in need which is a core principle of Islam.

Jan 1, 2022 | indiantelevision.com

Sun Pharmaceutical launched Brivaracetam in the India on Feb 1st 21'.

In February 2021, Sun Pharmaceutical Industries on announced its plans to introduce a complete range of anti-epilepsy drug Brivaracetam in the India at an affordable price.

Jan 1, 2022 | digitaljournal.com

Cipher Pharmaceuticals Inc. partnered with Sun Pharmaceutical on May 12th 22'.

"With disciplined cost reductions and the extension of the agreement with Sun Pharma, we believe that that Cipher now has a stable runway for growth.

Jan 1, 2022 | stockhouse.com

Sun Pharmaceutical launched oral lipid lowering drug, Bempedoic Acid, in India for reducing low-density lipoprotein cholesterol on May 25th 22'.

Ahmedabad: Sun Pharmaceutical Industries Ltd on Wednesday announced its wholly-owned subsidiary is soon to launch an oral lipid lowering drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol.

Jan 1, 2022 | indiatimes.com

Sun Pharmaceutical launched Ilumya and Cequa in Canada on May 1st 22'.

Sun Pharma has recently launched Ilumya and Cequa in Canada.

Jan 1, 2022 | business-standard.com

Sun Pharmaceutical has issues with recall their injectable treatment for vitamin B12 deficiency

Aurobindo Pharmaceutical and Sun Pharma have been forced to recall their injectable treatment for vitamin B12 deficiency- Cyanocobalamin and dry eye drug Cequa, respectively, for the same reason.

Jan 1, 2022 | lifescivoice.com

Sun Pharmaceutical launched WINLEVI in the US market on Nov 1st 21'.

Sun Pharma had then launched WINLEVI in the US market in November 2021.

Jan 1, 2022 | indiatimes.com

Sun Pharmaceutical launched Winlevi on Nov 1st 21'.

Sun Pharma launched Winlevi in the U.S. market in November 2021.

Jan 1, 2022 | drugstorenews.com

Sun Pharmaceutical sold assets to Ferring Pharmaceuticals on Jan 1st 19'.

Likewise, Ferring Pharmaceuticals added Ganirelix Acetate Injection to its product line in January 2019, acquiring the U.S. commercialization rights from Sun Pharmaceutical Industries Ltd.

Jan 1, 2021 | pharmiweb.com

Israel Makov retired from Sun Pharmaceutical as chairman and member of the board on Aug 11th 22'.

Sun Pharma today announced that its chairman and member of the board, Israel Makov, will retire from the company upon the completion of his current term at Sun Pharma’s Annual General Meeting on Aug. 29, after having led the organization for 10 years.

Jan 1, 2022 | drugstorenews.com

Sun Pharmaceutical hires Debbie Ricciardelli as manager fleet services

Debbie Ricciardelli was named manager fleet services at Sun Pharmaceuticals.

Jan 1, 2022 | globalfleetmanagement.com

Sun Pharmaceutical files suit against Hetero Healthcare Limited

Sun Pharma sued Hetero Healthcare for using the generic drug Letroz, which is used as a second-line treatment for advanced breast cancer, without permission.

Sep 6, 2022 | pharmastate.academy

Sun Pharmaceutical acquired Pharmalucence Inc. on Feb 1st 17'.

Pharma major Sun Pharmaceutical, on Wednesday, said that it has acquired Pharmalucence Inc, a US based injectable company for an undisclosed sum.

Jan 31, 2017 | pharmatips.in

QFR Solutions partners with Sun Pharmaceutical

Diana Harbort, CEO of Cassiopea SpA, commented: “QFR Solutions is very pleased to partner with Sun Pharma.

Jul 25, 2021 | qfrsolutions.com

Sun Pharmaceutical launched PrILUMYA on Oct 1st 21'.

In October 2021, Sun Pharma launched PrILUMYA (tildrakizumab injection) for people with moderate-to-severe plaque psoriasis in the Canada region.

Nov 21, 2022 | asdreports.com

Sun Pharmaceutical expands facilities to Maduranthakam, Tamil Nadu, India

Rs 10 crore on Sun Pharma for expanding its drug manufacturing facility in Maduranthagam allegedly without required environmental clearance from the concerned authority.

Dec 6, 2022 | pharmastate.academy

Sun Pharmaceutical recognized as Best Workplaces™ in Pharmaceuticals on Jan 1st 22'.

As a part of the assessment conducted by Great Place To Work® India, Sun Pharma was recognised among India’s Best Workplaces™ in Pharmaceuticals, Healthcare and Biotech 2022.

Dec 22, 2022 | indiaeducationdiary.in
See More